Farmers Trust Co. Sells 26 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Farmers Trust Co. reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.6% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,552 shares of the healthcare conglomerate’s stock after selling 26 shares during the period. Farmers Trust Co.’s holdings in UnitedHealth Group were worth $907,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the company. CFS Investment Advisory Services LLC raised its stake in shares of UnitedHealth Group by 55.0% in the fourth quarter. CFS Investment Advisory Services LLC now owns 2,760 shares of the healthcare conglomerate’s stock worth $1,453,000 after acquiring an additional 979 shares during the last quarter. CenterBook Partners LP lifted its holdings in UnitedHealth Group by 69.6% during the 4th quarter. CenterBook Partners LP now owns 11,749 shares of the healthcare conglomerate’s stock worth $6,185,000 after buying an additional 4,821 shares in the last quarter. AdvisorShares Investments LLC acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at $416,000. Delaney Dennis R lifted its stake in shares of UnitedHealth Group by 13.0% during the fourth quarter. Delaney Dennis R now owns 8,051 shares of the healthcare conglomerate’s stock valued at $4,239,000 after acquiring an additional 925 shares during the period. Finally, Broderick Brian C increased its position in UnitedHealth Group by 4.0% in the fourth quarter. Broderick Brian C now owns 18,607 shares of the healthcare conglomerate’s stock worth $9,796,000 after purchasing an additional 713 shares during the period. 87.86% of the stock is owned by institutional investors.

Insider Buying and Selling at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at approximately $16,812,029.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. Corporate insiders own 0.33% of the company’s stock.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of analyst reports. Royal Bank of Canada lifted their target price on shares of UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a report on Wednesday, July 17th. Truist Financial upped their target price on shares of UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Wells Fargo & Company boosted their price target on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Robert W. Baird lifted their target price on UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a report on Wednesday, July 17th. Finally, Argus upped their price target on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Two investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $614.17.

UnitedHealth Group Stock Up 0.1 %

UNH opened at $592.75 on Friday. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $607.94. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88. The stock has a fifty day moving average of $581.82 and a 200-day moving average of $526.64. The company has a market capitalization of $547.36 billion, a P/E ratio of 36.23, a P/E/G ratio of 1.62 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. During the same period last year, the firm earned $6.14 EPS. The business’s quarterly revenue was up 6.4% compared to the same quarter last year. On average, equities analysts expect that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 annualized dividend and a yield of 1.42%. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.